These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

672 related items for PubMed ID: 18199555

  • 1. Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells.
    Memmott RM, Gills JJ, Hollingshead M, Powers MC, Chen Z, Kemp B, Kozikowski A, Dennis PA.
    Cancer Res; 2008 Jan 15; 68(2):580-8. PubMed ID: 18199555
    [Abstract] [Full Text] [Related]

  • 2. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
    Han S, Khuri FR, Roman J.
    Cancer Res; 2006 Jan 01; 66(1):315-23. PubMed ID: 16397245
    [Abstract] [Full Text] [Related]

  • 3. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
    Lin CC, Yeh HH, Huang WL, Yan JJ, Lai WW, Su WP, Chen HH, Su WC.
    Am J Respir Cell Mol Biol; 2013 Aug 01; 49(2):241-50. PubMed ID: 23526220
    [Abstract] [Full Text] [Related]

  • 4. eNOS activation mediated by AMPK after stimulation of endothelial cells with histamine or thrombin is dependent on LKB1.
    Thors B, Halldórsson H, Thorgeirsson G.
    Biochim Biophys Acta; 2011 Feb 01; 1813(2):322-31. PubMed ID: 21145922
    [Abstract] [Full Text] [Related]

  • 5. The tumor suppressor gene TUSC2 (FUS1) sensitizes NSCLC to the AKT inhibitor MK2206 in LKB1-dependent manner.
    Meng J, Majidi M, Fang B, Ji L, Bekele BN, Minna JD, Roth JA.
    PLoS One; 2013 Feb 01; 8(10):e77067. PubMed ID: 24146957
    [Abstract] [Full Text] [Related]

  • 6. Ca2+/calmodulin-dependent protein kinase kinase is involved in AMP-activated protein kinase activation by alpha-lipoic acid in C2C12 myotubes.
    Shen QW, Zhu MJ, Tong J, Ren J, Du M.
    Am J Physiol Cell Physiol; 2007 Oct 01; 293(4):C1395-403. PubMed ID: 17687000
    [Abstract] [Full Text] [Related]

  • 7. AMPK/TSC2/mTOR-signaling intermediates are not necessary for LKB1-mediated nuclear retention of PTEN tumor suppressor.
    Liu JL, Mao Z, Gallick GE, Yung WK.
    Neuro Oncol; 2011 Feb 01; 13(2):184-94. PubMed ID: 21123367
    [Abstract] [Full Text] [Related]

  • 8. Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer.
    Carretero J, Medina PP, Blanco R, Smit L, Tang M, Roncador G, Maestre L, Conde E, Lopez-Rios F, Clevers HC, Sanchez-Cespedes M.
    Oncogene; 2007 Mar 08; 26(11):1616-25. PubMed ID: 16953221
    [Abstract] [Full Text] [Related]

  • 9. LKB1 gene inactivation does not sensitize non-small cell lung cancer cells to mTOR inhibitors in vitro.
    Xiao P, Sun LL, Wang J, Han RL, Ma Q, Zhong DS.
    Acta Pharmacol Sin; 2015 Sep 08; 36(9):1107-12. PubMed ID: 26027660
    [Abstract] [Full Text] [Related]

  • 10. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase.
    Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM, Frenguelli BG, Hardie DG.
    Cell Metab; 2005 Jul 08; 2(1):9-19. PubMed ID: 16054095
    [Abstract] [Full Text] [Related]

  • 11. Regulation of AMP-activated protein kinase by LKB1 and CaMKK in adipocytes.
    Gormand A, Henriksson E, Ström K, Jensen TE, Sakamoto K, Göransson O.
    J Cell Biochem; 2011 May 08; 112(5):1364-75. PubMed ID: 21312243
    [Abstract] [Full Text] [Related]

  • 12. A subset of VEGFR-TKIs activates AMPK in LKB1-mutant lung cancer.
    Yang L, Zhang Q, Xiong Y, Dang Z, Xiao H, Chen Q, Dai X, Zhang L, Zhu J, Wang D, Li M.
    Cancer Sci; 2023 Apr 08; 114(4):1651-1662. PubMed ID: 36459496
    [Abstract] [Full Text] [Related]

  • 13. AMP-activated protein kinase contributes to zinc-induced neuronal death via activation by LKB1 and induction of Bim in mouse cortical cultures.
    Eom JW, Lee JM, Koh JY, Kim YH.
    Mol Brain; 2016 Feb 09; 9():14. PubMed ID: 26856538
    [Abstract] [Full Text] [Related]

  • 14. Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties.
    MacDonald AF, Bettaieb A, Donohoe DR, Alani DS, Han A, Zhao Y, Whelan J.
    BMC Complement Altern Med; 2018 Jun 18; 18(1):188. PubMed ID: 29914450
    [Abstract] [Full Text] [Related]

  • 15. The Effect of LKB1 Activity on the Sensitivity to PI3K/mTOR Inhibition in Non-Small Cell Lung Cancer.
    Shukuya T, Yamada T, Koenig MJ, Xu J, Okimoto T, Li F, Amann JM, Carbone DP.
    J Thorac Oncol; 2019 Jun 18; 14(6):1061-1076. PubMed ID: 30825612
    [Abstract] [Full Text] [Related]

  • 16. Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer.
    Lee HY, Oh SH, Suh YA, Baek JH, Papadimitrakopoulou V, Huang S, Hong WK.
    Clin Cancer Res; 2005 Aug 15; 11(16):6065-74. PubMed ID: 16115952
    [Abstract] [Full Text] [Related]

  • 17. Aurora-A-mediated phosphorylation of LKB1 compromises LKB1/AMPK signaling axis to facilitate NSCLC growth and migration.
    Zheng X, Chi J, Zhi J, Zhang H, Yue D, Zhao J, Li D, Li Y, Gao M, Guo J.
    Oncogene; 2018 Jan 25; 37(4):502-511. PubMed ID: 28967900
    [Abstract] [Full Text] [Related]

  • 18. Negative regulation of AMP-activated protein kinase (AMPK) activity by macrophage migration inhibitory factor (MIF) family members in non-small cell lung carcinomas.
    Brock SE, Rendon BE, Yaddanapudi K, Mitchell RA.
    J Biol Chem; 2012 Nov 02; 287(45):37917-25. PubMed ID: 22988252
    [Abstract] [Full Text] [Related]

  • 19. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
    Nagalingam A, Arbiser JL, Bonner MY, Saxena NK, Sharma D.
    Breast Cancer Res; 2012 Feb 21; 14(1):R35. PubMed ID: 22353783
    [Abstract] [Full Text] [Related]

  • 20. Carnosic Acid against Lung Cancer: Induction of Autophagy and Activation of Sestrin-2/LKB1/AMPK Signalling.
    O'Neill EJ, Sze NSK, MacPherson REK, Tsiani E.
    Int J Mol Sci; 2024 Feb 06; 25(4):. PubMed ID: 38396629
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.